Not intended for distribution in the USA , Canada or the UK Key ESMO Abstracts # BAVENCIO ® (avelumab): 1451; 3152; 4174; 4256; 4823; 5113, ERBITUX ® (cetuximab): 1212, 2589, 4455, Tepotinib (MET kinase …

source https://finance.yahoo.com/news/data-esmo-2019-merck-highlight-060000844.html?.tsrc=rss